Kits Eyecare Ltd.
KITS.TO · TSX
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.23 | -1.36 | 0.01 | -21.89 |
| FCF Yield | 0.33% | 0.12% | 1.05% | 0.22% |
| EV / EBITDA | 1,961.02 | 121.27 | 49.10 | 345.93 |
| Quality | ||||
| ROIC | -0.77% | 2.44% | 4.32% | 0.26% |
| Gross Margin | 36.31% | 36.73% | 36.29% | 32.94% |
| Cash Conversion Ratio | 1.52 | -2.29 | 0.30 | 1.39 |
| Growth | ||||
| Revenue 3-Year CAGR | 18.89% | 19.37% | 19.92% | 20.25% |
| Free Cash Flow Growth | 233.97% | -82.44% | 275.52% | -69.56% |
| Safety | ||||
| Net Debt / EBITDA | -42.77 | -2.63 | -1.31 | -6.56 |
| Interest Coverage | -2.82 | 14.49 | 6.39 | 4.05 |
| Efficiency | ||||
| Inventory Turnover | 1.55 | 1.22 | 1.27 | 1.64 |
| Cash Conversion Cycle | 1.95 | 3.83 | 7.15 | -13.10 |